CDKN2A and oropharynx cancer: p16, also known as cyclin-dependent kinase inhibitor 2A, was discovered in 1994 as a tumor suppressor gene similar to p53 and has attracted attention as a surrogate marker for human papillomavirus (HPV) infection in HPV-related oropharyngeal cancer (40).